Adverum Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Augustus Stern, MD(5.37%)
Adverum Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Principia Wealth Advisory, LLC, EIN: 27-1545452(5.07%)
Adverum Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(7.2%)
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Soparkar Peter
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Seyedkazemi Setareh
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Rubinstein Linda M
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Fischer Laurent
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Ozden Rabia Gurses
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-10% Owner Leonard Braden Michael
Adverum Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Braden M Leonard(10.6%),BML Investment Partners, L.P.(10.1%)
Adverum Biotechnologies | 3: Initial statement of beneficial ownership of securities-10% Owner Leonard Braden Michael
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-10% Owner Leonard Braden Michael
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director Svoronos Dawn
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Ozden Rabia Gurses
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director Nicholson, C. David
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director Hong Soo
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director Lupher, Jr. Mark L.
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director Kiss Szilard
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director Machado Patrick
Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Director Scopa James Paul
No Data
No Data